Skip to main content

Advertisement

SpringerLink
Log in

Treatment of cerebellar masses

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Cerebellar masses are a heterogenous group of conditions that can cause compression of the aqueduct or fourth ventricle, resulting in obstructive hydrocephalus, brainstem compression, and upward/downward herniation as a direct result of mass effect. Untreated lesions can be fatal in a few hours, but prompt and appropriate treatment of the mass effect can produce very good outcomes. These patients should be closely followed in a critical care setting that has rapid access to neurosurgical expertise. Medical measures to decrease brain edema should be taken, including elevation of the head of the bed and avoidance of hypo-osmolar solutions, hypercarbia, or hyperthermia. Osmotic diuretics should be initiated promptly in patients with clinical worsening and radiographic evidence of edema resulting in mass effect. However, medical measures should not delay surgical intervention, which should proceed as rapidly as possible when indicated. Cerebellar hemorrhages more than 3 cm in diameter and cerebellar hemispheric strokes involving more than one third of the hemisphere should be considered for early suboccipital craniotomy with decompression. Regardless of lesion size, neurologic deterioration and radiologic signs of obstructive hydrocephalus should call for emergency decompressive surgery with resection of hematoma or necrotic brain tissue. Ventriculostomy should be considered as a bridge to surgical decompression, given the theoretical concern of upward herniation mediated by supratentorial drainage in the face of an underlying posterior fossa mass lesion. Steroids are not indicated for cerebrovascular disease but should be used to treat vasogenic edema induced by tumor. Anticoagulation is reserved for cerebellar venous and dural sinus thrombosis. Specific treatments targeting the underlying pathology should be used aggressively: thrombolysis and endovascular interventions for eligible stroke patients, antibiotic therapy for abscesses, and radiotherapy, chemotherapy, or both for tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bogousslavsky J, Van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988, 19:1083–1092

    PubMed  CAS  Google Scholar 

  2. Freeman RE, Onofrio BM, Okazaki H, Dinapoli RP: Spontaneous intracerebellar hemorrhage. Diagnosis and surgical treatment. Neurology 1973, 23:84–90

    PubMed  CAS  Google Scholar 

  3. Gurol ME, Krespi Y, Tugcu B, et al.: Istanbul Stroke registry: analysis of 1260 consecutive patients. Eur J Neurology 2001, 8(Suppl 2):13

    Google Scholar 

  4. Flaherty ML, Woo D, Haverbusch M, et al.: Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005, 36:934–937

    Article  PubMed  Google Scholar 

  5. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al.: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001: 32:891–897

    PubMed  Google Scholar 

  6. Amarenco P: The spectrum of cerebellar infarctions. Neurology 1991, 41:973–979

    PubMed  CAS  Google Scholar 

  7. Krespi Y, Gurol ME, Coban O, et al.: Venous infarction of brainstem and cerebellum. J Neuroimaging 2001, 11:425–431

    Article  PubMed  CAS  Google Scholar 

  8. Stein BM, Solomon R.A: Surgical approaches to posterior fossa arteriovenous malformations. Clin Neurosurg 1991, 37:353–371

    PubMed  CAS  Google Scholar 

  9. Symon L, Tacconi L, Mendoza N, Nakaji P: Arteriovenous malformations of the posterior fossa: a report on 28 cases and review of the literature. Br J Neurosurg 1995, 9:721–732

    Article  PubMed  CAS  Google Scholar 

  10. DeAngelis LM, Gutin PH, Leibel SA, Posner JB: Intracranial Tumors. London: Martin Dunitz; 2002.

    Google Scholar 

  11. Smirniotopoulos JG, Yue NC, Rushing EJ: Cerebellopontine angle masses: radiologic-pathologic correlation. Radiographics 1993, 13:1131–1147

    PubMed  CAS  Google Scholar 

  12. Kastenbauer S, Pfister HW, Wispelwey B, Scheld WM: Brain abscess. In Infections of the Central Nervous System. Edited by Scheld WM, Whitley RJ, Marra CM. Philadelphia: Lippincott Williams & Wilkins; 2004:479–507.

    Google Scholar 

  13. Heros RC: Cerebellar hemorrhage and infarction. Stroke 1982, 13:106–109

    PubMed  CAS  Google Scholar 

  14. Amarenco P, Hauw JJ: Cerebellar infarction in the territory of the anterior and inferior cerebellar artery. A clinicopathological study of 20 cases. Brain 1990, 113(Pt 1):139–155

    Article  PubMed  Google Scholar 

  15. Amarenco P, Hauw JJ, Gautier J.C: Arterial pathology in cerebellar infarction. Stroke 1990, 21:1299–1305

    PubMed  CAS  Google Scholar 

  16. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587

    Article  Google Scholar 

  17. Clark WM, Wissman S, Albers GW, et al.: Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999, 282:2019–2026

    Article  PubMed  CAS  Google Scholar 

  18. Hacke W, Kaste M, Fieschi C, et al.: Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998. 352:1245–1251

    Article  PubMed  CAS  Google Scholar 

  19. Hacke W, Donnan G, Fieschi C, et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768–774.

    Article  PubMed  Google Scholar 

  20. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003–2011.

    Article  PubMed  CAS  Google Scholar 

  21. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1438.

    Article  PubMed  Google Scholar 

  22. IMS II Trial Investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38:2127–2135.

    Article  Google Scholar 

  23. Kase CS, Norrving B, Levine SR, et al.: Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke 1993, 24:76–83.

    PubMed  CAS  Google Scholar 

  24. Koh MG, Phan TG, Atkinson JLD, Wijdicks EFM: Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect. Stroke 2000, 31:2062–2067.

    PubMed  CAS  Google Scholar 

  25. Macdonell RA, Kalnins RM, Donnan GA: Cerebellar infarction: natural history, prognosis, and pathology. Stroke 1987, 18:849–855.

    PubMed  CAS  Google Scholar 

  26. Chen HJ, Lee TC, Wei CP: Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 1992, 23:957–961.

    PubMed  CAS  Google Scholar 

  27. Mathew P, Teasdale G, Bannan A, Oluoch-Olunya D: Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 1995, 59:287–292.

    Article  PubMed  CAS  Google Scholar 

  28. Rieke K, Krieger D, Adams HP, Aschoff A: Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data. Cerebrovasc Dis 1993, 3:45–55.

    Article  Google Scholar 

  29. Heros RC: Surgical treatment of cerebellar infarction. Stroke 1992, 23:937–938.

    PubMed  CAS  Google Scholar 

  30. Jensen MB, St. Louis EK: Management of acute cerebellar stroke. Arch Neurol 2005, 62:537–544.

    Article  PubMed  Google Scholar 

  31. Jauss M, Krieger D, Hornig C, et al.: Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study. J Neurol 1999, 246:257–264.

    Article  PubMed  CAS  Google Scholar 

  32. Adams HP Jr, del Zoppo G, Alberts MJ, et al.: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007, 115:e478–e534.

    Article  PubMed  Google Scholar 

  33. Henderson GV: Management of massive cerebral infarct. Curr Neurol Neurosci Rep 2004: 4:497–504.

    Article  PubMed  Google Scholar 

  34. Bereczki D, Liu M, Prado GF, Fekete I: Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000, 31:2719–2722.

    PubMed  CAS  Google Scholar 

  35. Larsson O, Marinovich N, Barber K: Double-blind trial of glycerol therapy in early stroke. Lancet 1976, 1(7964):832–834.

    Article  PubMed  CAS  Google Scholar 

  36. Robertson C: Every breath you take: hyperventilation and intracranial pressure. Cleve Clin J Med 2004; 71(Suppl 1):S14–S15.

    PubMed  Google Scholar 

  37. Mulley G, Wilcox RG, Mitchell JR: Dexamethasone in acute stroke. Br Med J 1978, 2(6143):994–996.

    PubMed  CAS  Google Scholar 

  38. Norris JW: Steroid therapy in acute cerebral infarction. Arch Neurol 1976, 33:69–71.

    PubMed  CAS  Google Scholar 

  39. Poungvarin N, Bhoopat W, Viriyavejakul A, et al.: Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987, 316:1229–1233.

    Article  PubMed  CAS  Google Scholar 

  40. Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785.

    Article  PubMed  CAS  Google Scholar 

  41. Mayer SA, Brun N.C, Begtrup K, et al.: Randomized, placebo-controlled, double-blind phase III study to assess rFVIIa efficacy in acute intracerebral hemorrhage: the fast trial [abstract]. In Abstracts of the 16th European Stroke Conference. Glasgow, United Kingdom, 2007:10.

  42. Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387–397.

    PubMed  Google Scholar 

  43. Holtkamp M: The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 2007, 20:188–193.

    Article  PubMed  CAS  Google Scholar 

  44. Claassen J, Jette N, Chum F, et al.: Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007, 69:1356–1365.

    Article  PubMed  CAS  Google Scholar 

  45. St. Louis EK, Wijdicks EF, Li H: Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology 1998, 51:1364–1369.

    PubMed  CAS  Google Scholar 

  46. St. Louis EK, Wijdicks EF, Li H, Atkinson JD: Predictors of poor outcome in patients with a spontaneous cerebellar hematoma. Can J Neurol Sci 2000: 27:32–36.

    PubMed  CAS  Google Scholar 

  47. Kirollos RW, Tyagi AK, Ross SA, et al.: Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 2001, 49:1378–1386; discussion 1386–1387.

    Article  Google Scholar 

  48. Cohen ZR, Ram Z, Knoller N, et al.: Management and outcome of non-traumatic cerebellar haemorrhage. Cerebrovasc Dis 2002, 14:207–213.

    Article  PubMed  Google Scholar 

  49. Yamamoto T, Nakao Y, Mori K, Maeda M: Endoscopic hematoma evacuation for hypertensive cerebellar hemorrhage. Minim Invasive Neurosurg 2006, 49:173–178.

    Article  PubMed  CAS  Google Scholar 

  50. Miranda P, Alday R, Lagares A, et al.: Posterior fossa subdural hematoma mimicking intracerebellar hemorrhage. Neurocirugia (Astur) 2003, 14:526–528.

    CAS  Google Scholar 

  51. Pal D, Gnanalingham K, Peterson D: A case of spontaneous acute subdural haematoma in the posterior fossa following anticoagulation. Br J Neurosurg 2004, 18:68–69.

    Article  PubMed  CAS  Google Scholar 

  52. Datta NN, Chan KY, Kwok JC, Poon CY: Posterior fossa subdural hematoma due to ruptured arteriovenous malformation [case report]. Neurosurg Focus 2000, 8(6):ecp1. http://www.aans.org/education/journal/neurosurgical/june00/8-6-cp.pdf

    Google Scholar 

  53. Einhaupl K, Bousser MG, de Bruijn SF, et al.: EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006, 13:553–559.

    Article  PubMed  CAS  Google Scholar 

  54. Ciccone A, Canhão P, Falcao F, et al.: Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004:CD003693.

  55. Khaw AV, Mohr JP, Sciacca RR, et al.: Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004, 35:660–663.

    Article  PubMed  CAS  Google Scholar 

  56. Batjer H, Samson D: Arteriovenous malformations of the posterior fossa. Clinical presentation, diagnostic evaluation, and surgical treatment. J Neurosurg 1986, 64:849–856.

    PubMed  CAS  Google Scholar 

  57. Silber MH, Sandok BA, Earnest FT: Vascular malformations of the posterior fossa. Clinical and radiologic features. Arch Neurol 1987, 44:965–969.

    PubMed  CAS  Google Scholar 

  58. Coert BA, Chang SD, Do HM, et al.: Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg 2007, 106:855–865.

    Article  PubMed  Google Scholar 

  59. Lubicz B, Leclerc X, Gauvrit JY, et al.: Giant vertebrobasilar aneurysms: endovascular treatment and long-term follow-up. Neurosurgery 2004, 55:316–323; discussion 323–326.

    Article  PubMed  Google Scholar 

  60. Conway JE, Chou D, Clatterbuck RE, et al.: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 2001, 48:55–62; discussion 62–63.

    Article  PubMed  CAS  Google Scholar 

  61. Robinson S, Cohen AR: Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature. Neurosurg Focus 2006, 20(1):E6. http://www.aans.org/education/journal/neurosurgical/jan06/20-1-6.pdf

    Google Scholar 

  62. Nowak DA, Trost HA: Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 2002, 105:137–145.

    Article  PubMed  CAS  Google Scholar 

  63. Galicich JH, French LA: Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat 1961, 12:169–174.

    PubMed  CAS  Google Scholar 

  64. Carpenter J, Stapleton S, Holliman R: Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 2007, 26:1–11.

    Article  PubMed  CAS  Google Scholar 

  65. Moore AJ, Newell DW: Neurosurgery: Principles and Practice. London: Springer; 2005.

    Google Scholar 

  66. Rosenblum ML, Mampalam TJ, Pons VG: Controversies in the management of brain abscesses. Clin Neurosurg 1986, 33:603–632.

    PubMed  CAS  Google Scholar 

  67. Cruz, J, Minoja G, Okuchi K: Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery 2002, 51:628–637; discussion 637–638.

    Article  PubMed  Google Scholar 

  68. Vialet R, Albanese J, Thomachot L, et al.: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003, 31:1683–1687.

    Article  PubMed  CAS  Google Scholar 

  69. Bhardwaj A, Ulatowski JA: Cerebral edema: hypertonic saline solutions. Curr Treatment Options Neurol 1999, 1:179–188.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA

    Erik K. St. Louis

Authors
  1. Mahmut Edip Gurol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erik K. St. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erik K. St. Louis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gurol, M.E., St. Louis, E.K. Treatment of cerebellar masses. Curr Treat Options Neurol 10, 138–150 (2008). https://doi.org/10.1007/s11940-008-0015-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-008-0015-z

Keywords

Search

Navigation